928025-42-7 Usage
Uses
Used in Pharmaceutical Industry:
(R)-1-benzyl-3-butylpiperazine is used as a psychiatric drug for its potential antipsychotic effects, aiming to provide treatment for various mental health conditions.
Used in Addiction Treatment:
(R)-1-benzyl-3-butylpiperazine is used as an addiction treatment agent to help individuals recover from substance abuse, leveraging its potential to address the underlying causes of addiction.
Used in Mood Disorder Treatment:
(R)-1-benzyl-3-butylpiperazine is used as a treatment for mood disorders such as depression and anxiety, due to its interaction with serotonin receptors, which play a crucial role in regulating mood and emotional well-being.
Check Digit Verification of cas no
The CAS Registry Mumber 928025-42-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,8,0,2 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 928025-42:
(8*9)+(7*2)+(6*8)+(5*0)+(4*2)+(3*5)+(2*4)+(1*2)=167
167 % 10 = 7
So 928025-42-7 is a valid CAS Registry Number.
928025-42-7Relevant articles and documents
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 17-18, (2008/06/13)
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of
17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 17, (2010/02/05)
There are disclosed compounds of the formula (I): prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases.
